Eric Jullian

Kisten ras mutations in patients with colorectal cancer: the “RASCAL II” study.

David Cunningham, J. Oates, Joanne Young et al. · IRIS UNIMORE (University of Modena and Reggio Emilia) · 2001 · 890 citations · Full text

Medicine, Genetics, Oncology +12

Mutations of <i>β-Catenin</i> in Adrenocortical Tumors: Activation of the Wnt Signaling Pathway Is a Frequent Event in both Benign and Malignant Adrenocortical Tumors

Frédérique Tissier, Catherine Cavard, Lionel Groussin et al. · Cancer Research · 2005 · 464 citations

Medicine, Genetics, Oncology +17

Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial1 1The authors thank the women and men who participated in the study, P. E. Douziech for coordination of treatments, and the hospital pharmacists for preparation of the treatments in the trial centers.

Robert Benamouzig, Jacques Deyra, Antoine Martin et al. · Gastroenterology · 2003 · 395 citations

Medicine, Pharmacology, Pharmacotherapy +13

Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study

Jervoise Andreyev, A. R. Norman, David Cunningham et al. · British Journal of Cancer · 2001 · 204 citations · Full text

Medicine, Genetics, Oncology +13

Molecular Analysis of the Cyclic AMP-Dependent Protein Kinase A (PKA) Regulatory Subunit 1A (PRKAR1A) Gene in Patients with Carney Complex and Primary Pigmented Nodular Adrenocortical Disease (PPNAD) Reveals Novel Mutations and Clues For Pathophysiology: Augmented PKA Signaling is Associated with Adrenal Tumorigenesis in PPNAD

Lionel Groussin, Lawrence S. Kirschner, Caroline Vincent-Dejean et al. · The American Journal of Human Genetics · 2002 · 187 citations · Full text

Life Sciences, Endocrinology, Molecular Genetics +17